The cannabis industry stands at a pivotal moment as cannabis rescheduling to Schedule III looms on the horizon. In a recent Qredible Live broadcast, host Brian Fitzpatrick, CEO of Qredible, sat down with distinguished attorney Aaron Pelley to unpack what this means for cannabis businesses nationwide. With over 17 years of experience navigating complex regulatory […]
The potential rescheduling of cannabis from Schedule I to Schedule III represents one of the most anticipated regulatory changes in 2024. During a recent Qredible Live webinar, Mike Goral of Armanino LLP and Colin Campbell of Campfire Advisors shared insights about the complex realities behind this potential shift and what it means for cannabis businesses. […]
The Drug Enforcement Administration (DEA) recently postponed its decision on reclassifying marijuana under federal law, with a hearing set for December 2, 2024. This delay means that any final decision on marijuana rescheduling won’t be made until after the November presidential election, potentially delaying until 2025. The rescheduling, proposed by the Biden administration, follows an […]
The potential rescheduling of cannabis under the Controlled Substances Act (CSA) has been a hotly debated topic for years. With the recent recommendation by the Department of Health and Human Services (HHS) to move cannabis from Schedule I to Schedule III, the question of how this will impact FDA oversight and regulation takes center stage. […]
Running a cannabis business is exciting, but let's be honest, it also comes with its fair share of complexities. Between ever-evolving regulations and the intricate dance of abundant cannabis taxes, staying ahead of the curve can feel like running a marathon uphill. Speaking of taxes, whispers of potential cannabis tax changes are swirling around the […]
The possibility of marijuana legalization at a national level has been a hot topic in recent years, with individual states taking matters into their own hands by legalizing the plant independently. A recent recommendation of marijuana reclassification by federal health officials has sparked hope for a crucial step toward national legalization. However, the implications of […]
